DOI QR코드

DOI QR Code

Effect of Persicae Semen for Atopic Dermatitis Skin Tissue and Regulate to Inflammation Mediator in Serum

도인(桃仁)의 아토피 피부염 모델 피부조직 및 혈청 내 염증매개물질 조절 효과

  • Kim, Sangwoo (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Hong, SooYeon (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Kwon, Boguen (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Myunghyun (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Kim, Sang-bae (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Jin, Dae-hwan (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Choi, Woochan (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Sohn, Youngjoo (Department of Anatomy, College of Korean Medicine, Kyung Hee University) ;
  • Jung, Hyuk-Sang (Department of Anatomy, College of Korean Medicine, Kyung Hee University)
  • 김상우 (경희대학교 한의과대학 해부학교실) ;
  • 홍수연 (경희대학교 한의과대학 해부학교실) ;
  • 권보근 (경희대학교 한의과대학 해부학교실) ;
  • 김명현 (경희대학교 한의과대학 해부학교실) ;
  • 김상배 (경희대학교 한의과대학 해부학교실) ;
  • 진대환 (경희대학교 한의과대학 해부학교실) ;
  • 최우찬 (경희대학교 한의과대학 해부학교실) ;
  • 손영주 (경희대학교 한의과대학 해부학교실) ;
  • 정혁상 (경희대학교 한의과대학 해부학교실)
  • Received : 2020.06.03
  • Accepted : 2020.07.25
  • Published : 2020.07.30

Abstract

Objective : The objective of this study was to demonstrate the effect of Persicae Semen (PS) in DNCB-induced atopic dermatitis mouse and HaCaT cell. Methods : The BALB/c mice were divided into four groups. To develop atopic dermatitis, 200 ㎕ of 1 and 0.5% DNCB solution was put on the back of mice in the Control group, the PS-Low group and the PS-High group once a day. After application of DNCB, 200 ㎕ of the PS extract was also treated. The Normal group was given PBS. The mice dorsal skin was stained with Masson's trichrome, H&E, and toluidine blue to evaluate the thickness of the epidermis and dermis, infiltration of eosinophils and mast cells respectively. ELISA was applied to measure the serum level of IgE and IL-6. Toxicity of PS was measured by MTS assay in HaCaT cell. To investigate the effects of PS on HaCaT cells, cells were pre-treated with PS for 1h, and then stimulated with TNF-α and IFN-γ. After 24 hours, the expression of TARC was analyzed using RT-PCR. Results : PS not only significantly diminished the thickness of the epidermis and dermis, but also reduced the infiltration of eosinophil and mast cell in skin lesion. PS also reduced the serum IgE and IL-6 level which plated important roles in the atopic dermatitis. The expression of TARC was decreased significantly in TNF-α/IFN-γ stimulated HaCaT cell. Conclusion : These results suggest that PS may be effective in alleviating the atopic dermatitis induced by DNCB and inflammation by TNF-α/IFN-γ.

Keywords

References

  1. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid OA. New insights into atopic dermatitis. Journal of Clinical Investigation. 2004;113(5):651-57. https://doi.org/10.1172/JCI21060
  2. Otsuka A, Nomura T, Rerknimitr P, Seidel JA, Honda T, Kabashima K. The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunological Reviews. 2017;278(1):246-62. https://doi.org/10.1111/imr.12545
  3. Yoon NY, Wang HY, Jun M, Jung M, Kim DH, Lee NR, et al. Simultaneous detection of barrier- and immune-related gene variations in patients with atopic dermatitis by reverse blot hybridization assay. Clinical and Experimental Dermatology. 2018;43(4):430-36. https://doi.org/10.1111/ced.13367
  4. Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nature Reviews Disease Primers. 2018;4.
  5. Bieber T. Atopic Dermatitis. Annals of Dermatology. 2010;22(2):125-37. https://doi.org/10.5021/ad.2010.22.2.125
  6. KJ D. Textbook of Dermatology. Korean Medical Books. 2014:202-13.
  7. Kim JY, Yang Y. Effects of Atopic Dermatitis on Suicidal Ideation, Plans and Attempts in Young Adult. Journal of Korean Academy of Community Health Nursing. 2017;28(4):504-12. https://doi.org/10.12799/jkachn.2017.28.4.504
  8. Kim KH, Park AY, Kim JS. Factors associated with atopic dermatitis in Korean adults: the Korean National Health and Nutrition Survey 2008. The Korean Journal of Rehabilitation Nursing. 2012;15(2):83-90. https://doi.org/10.7587/kjrehn.2012.83
  9. Yun Y-H, Choi I-H. A study on the development of traditional korean medicine clinical practice guideline for atopic dermatitis. The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology. 2012;25(2):38-48. https://doi.org/10.6114/jkood.2012.25.2.038
  10. Kim K, Kim N, Kim Y, Kim J, Park M, Park S. Text of Traditional Korean Dermatology & Surgery. Busan: Seonu. 2007:129-33.
  11. S N. eBook of DERMATOLOGY. IBC planning company. 2006:489-538.
  12. Lee M. Development of clinical practice guideline on Korean Medicine using evidence based medicine. Daejeon: Institute of Oriental Medicine. 2013:3-17.
  13. Kim YH, Lee HC. 아토성 피부염에 관 (關) 한 동. 서의학적 (東. 西醫學的) 고찰 (考察). The Journal of Pediatrics of Korean Medicine. 1993;7(1):121-33.
  14. Sohn K, Lee J, Jee S. A philological study on demonstration of atopic dermatitis. J East-West Med. 2009;34(4):15-24.
  15. Gu D-M. A clinical study based on Sasang Consitutional Medicine on the treatment of atopic dermatitis. Journal of Sasang Constitutional Medicine. 2002;14(2):69-77.
  16. Son B-K, Choi I-H. 6 Cases of Acute Lesion of Atopic Dermatitis Diagnosed as damp-heat type. The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology. 2007;20(2):213-29.
  17. Son SH, Ahn SH, Park S-Y, Kim K. Hwangnyeonhaedok-tang Extracts Ameliorates Atopic Dermatitis via Epidermal Lipid Barrier Regeneration in NC/Nga Mouse. The Journal of Pediatrics of Korean Medicine. 2018;32(3):90-99. https://doi.org/10.7778/JPKM.2018.32.3.090
  18. Kim J-E, Lee H-C, Kang E-J, Choi J-W, Kim J-H, Park S-Y, et al. Effects of Daecheonglyongtang on Atopic Dermatitis Induced by DNCB in Mice. The Journal of Korean Medicine Ophthalmology & Otolaryngology & Dermatology. 2019;32(3):58-76. https://doi.org/10.6114/JKOOD.2019.32.3.058
  19. Kim SH, Jung HS, Lee JY, Kim DG, Cho BG. Effect of Lithospermum erythrorhizon on the atopic dermatitis. The Journal of Pediatrics of Korean Medicine. 2004;18(1):63-75.
  20. Lee JY, Kim DG, Han KC. Effects of Arctii Fructus on the Atopic dermatitis. The Journal of Pediatrics of Korean Medicine. 2004;18(2):107-17.
  21. Kim K, Lee J, Kim D. Effects of Mori folium on the atopic dermatitis. J Kyung Hee Univ Med Cent. 2004;20(1):37-45.
  22. Park JM, Chae JW. Effects of Aurantii Immaturus Fructus (AI) on atopic dermatitis (AD) induced by DNCB in mice. The Journal of Pediatrics of Korean Medicine. 2015;29(1):27-43. https://doi.org/10.7778/jpkm.2015.29.1.027
  23. Lim KM, Ko HJ, Choi JH, Park SY, Kim JH, Jung M. Effects of Adenophorae Radix (AR) on Atopic Dermatitis (AD) Induced by DNCB in Mice. The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology. 2017;30(3):31-45. https://doi.org/10.6114/jkood.2017.30.3.031
  24. Committee NMUJTC. herbal medicine. Yeonglimsa. 2004:462-63.
  25. JH H. Oriental medicine Pharmacology. EuiSeongDang. 2004:377-79.
  26. HC K. Oriental medicine Pharmacology. Jibmoondang. 2017:336-37.
  27. Wang N, Liu Q, Peng D, Wang L, Wang S. Experimental study on anti-thrombus effect of different extracts from Semen Persicae. Zhong yao cai= Zhongyaocai= Journal of Chinese medicinal materials. 2002;25(6):414-15.
  28. Fukuda T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biological and Pharmaceutical Bulletin. 2003;26(2):271-73. https://doi.org/10.1248/bpb.26.271
  29. Song M-Y, Kim H-J, Lee M-J. Neuroprotective Effect of Semen Persicae in Middle Cerebral Artery Occlusion Rats. J Korean Oriental Med. 2009;30(2):117-26.
  30. Hwang HJ, Lee HJ, Kim CJ, Shim I, Hahm DH. Inhibitory effect of amygdalin on lipopolysaccharideinducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J Microbiol Biotechnol. 2008;18(10):1641-47.
  31. Yang Y, Zhao J, Song X, Li L, Li F, Shang J, et al. Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-${\kappa}B$ signalling pathways. Artificial cells, nanomedicine, and biotechnology. 2019;47(1):2688-97. https://doi.org/10.1080/21691401.2019.1634084
  32. Lee HM, Moon A. Amygdalin regulates apoptosis and adhesion in Hs578T triple-negative breast cancer cells. Biomolecules & therapeutics. 2016;24(1):62. https://doi.org/10.4062/biomolther.2015.172
  33. GS K. Rare medical book integration. Han Seong Sa. 1976:111-12.
  34. SZ L. Bencao Gangmu. In Min Wi Saeng publishing Co. 2002:1742-44.
  35. Jun H. Donguibogam. BUBIN PUBLISHERS CO. 2011:847-76.
  36. Kim H, Park J. Inhibitory effect of saingheylyunbooem on compound 48/80 stimulated allergic reaction. Journal of Physiology & Pathology in Korean Medicine. 2010;24(1):48-54.
  37. Yu HY, Kim KB, Min SY, Kim JH. Case study of the effects of Saenghyeoryunbueum on atopic dermatitis. The Journal of Pediatrics of Korean Medicine. 2008;22(1):35-48.
  38. Kim GJ, Choi HG, Kim JH, Kim SH, Kim JA, Lee SH. Anti-allergic inflammatory effects of cyanogenic and phenolic glycosides from the seed of Prunus persica. Natural product communications. 2013;8(12):1934578X1300801221.
  39. Baroni A, Paoletti I, Greco R, Satriano R, Ruocco E, Tufano M, et al. Immunomodulatory effects of a set of amygdalin analogues on human keratinocyte cells. Experimental dermatology. 2005;14(11):854-59. https://doi.org/10.1111/j.1600-0625.2005.00368.x
  40. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. The Journal of clinical investigation. 1999;104(8):1097-105. https://doi.org/10.1172/JCI7613
  41. Yun J-W, Kim H, Kang H-J, Koh J-Y, Kim B-H. Comparative evaluation of animal models for atopic dermatitis in NC/Nga mice. Laboratory Animal Research. 2008;24(1):59-66.
  42. Lee KS, Jeong ES, Heo SH, Seo JH, Jeong DG, Choi YK. A novel model for human atopic dermatitis: application of repeated DNCB patch in BALB/c mice, in comparison with NC/Nga mice. Laboratory Animal Research. 2010;26(1):95-102. https://doi.org/10.5625/lar.2010.26.1.95
  43. Ahn S, Park B, Won J, Cheon S. An Atlas of Atopic Eczema. Seoul: Koonja publishing INC. 2007:107-15.
  44. GH K. Color atlas of dermatopathology. The Korean Society For Investigative Dermatology. 2017:83-90.
  45. Neutelings T, Nusgens BV, Liu Y, Tavella S, Ruggiu A, Cancedda R, et al. Skin physiology in microgravity: a 3-month stay aboard ISS induces dermal atrophy and affects cutaneous muscle and hair follicles cycling in mice. npj Microgravity. 2015;1:15002. https://doi.org/10.1038/npjmgrav.2015.2
  46. Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561-70. https://doi.org/10.1111/j.1398-9995.2004.00476.x
  47. Kim JW LG. Atopic dermatitis. Gun Ja publishing Co. 2017:9-10, 12-13, 23-28, 37-40, 45-46, 71, 95-105.
  48. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nature Reviews Immunology. 2007;7(2):93-104. https://doi.org/10.1038/nri2018
  49. Irani AMA, Sampson HA, Schwartz LB. Mast cells in atopic dermatitis. Allergy. 1989;44:31-34.
  50. Kanbe T, Soma Y, Kawa Y, Kashima M, Mizoguchi M. Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity. British Journal of Dermatology. 2001;144(6):1148-53. https://doi.org/10.1046/j.1365-2133.2001.04224.x
  51. Leung DY BT. Atopic dermatitis. 2003;361:151-60.
  52. Alan DI PH, Albert CY. Harper's Textbook of Pediatric Dermatology. Wiley-Blackwell. 2011;161:1-6.
  53. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Molecular immunology. 2002;39(9):531-36. https://doi.org/10.1016/S0161-5890(02)00210-9
  54. Hong SJ, Lee WJ, Jo EH, Ahn SH. The Effect of Lactobacillus Mixture Culture Fluid Extracts on Atopic Dermatitis Chemokine Expression of in HaCaT Cells. Korean Journal of Acupuncture. 2017;34(2):82-87. https://doi.org/10.14406/acu.2017.008
  55. Campbell J, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400(6746):776. https://doi.org/10.1038/23495
  56. Hijnen D, de Bruin-Weller M, Oosting B, Lebre C, de Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. Journal of allergy and clinical immunology. 2004;113(2):334-40. https://doi.org/10.1016/j.jaci.2003.12.007
  57. Vestergaard C, Bang K, Gesser B, Yoneyama H, Matsushima K, Larsen CG. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+ CCR4+ lymphocytes into lesional atopic dermatitis skin. Journal of Investigative Dermatology. 2000;115(4):640-46. https://doi.org/10.1046/j.1523-1747.2000.00115.x
  58. Shimada Y, Takehara K, Sato S. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis. Journal of dermatological science. 2004;34(3):201-08. https://doi.org/10.1016/j.jdermsci.2004.01.001
  59. Song TW, Kwon BC, Choi SY, Shin YH, Lee KE, Yang HS, et al. Increased serum thymus and activation-regulated chemokine (TARC) levels in children with atopic dermatitis. Pediatric Allergy and Respiratory Disease. 2005;15(3):250-56.